• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

大剂量放射性碘治疗转移性甲状腺癌后的白血病前期

Preleukemia following large dose radioiodide therapy for metastatic thyroid carcinoma.

作者信息

Yoosufani Z, Slavin J D, Hellman R M, Sethi S S, Spencer R P

出版信息

J Nucl Med. 1987 Aug;28(8):1348-50.

PMID:3612295
Abstract

A 67-yr-old woman had follicular thyroid carcinoma metastatic to several osseous sites. There was also evidence of functioning pulmonary metastases. She was treated by total thyroidectomy and multiple doses of radioiodide (131I). Approximately 2.5 yr after the initial ablative dose, and a total dose of 820 mCi of sodium iodide 131I, preleukemic changes were noted in the bone marrow. This appears to be the second case of preleukemia that bears a temporal relationship to radioiodide therapy of thyroid carcinoma, and the first in which radioiodide alone has been used in therapy (without additional external radiation).

摘要

一名67岁女性患有滤泡性甲状腺癌,已转移至多个骨部位。也有功能性肺转移的证据。她接受了甲状腺全切除术和多剂放射性碘(131I)治疗。在初始消融剂量后约2.5年,总共给予820毫居里的碘化钠131I后,骨髓中出现了白血病前期变化。这似乎是第二例与甲状腺癌放射性碘治疗存在时间关联的白血病前期病例,也是首例仅使用放射性碘进行治疗(无额外外照射)的病例。

相似文献

1
Preleukemia following large dose radioiodide therapy for metastatic thyroid carcinoma.大剂量放射性碘治疗转移性甲状腺癌后的白血病前期
J Nucl Med. 1987 Aug;28(8):1348-50.
2
[Experience with a high-dose therapy concept in metastatic differentiated thyroid cancer].[转移性分化型甲状腺癌高剂量治疗方案的经验]
Nuklearmedizin. 1988 Dec;27(6):266-71.
3
"High-dose" radioiodine therapy in advanced differentiated thyroid carcinoma.高剂量放射性碘治疗晚期分化型甲状腺癌
J Nucl Med. 1996 Sep;37(9):1496-503.
4
[Effectiveness of high-dosage radioiodine therapy in the elimination of remnant tissue following total thyroidectomy].[高剂量放射性碘治疗在全甲状腺切除术后残余组织清除中的有效性]
Nuklearmedizin. 1984 Oct;23(5):265-9.
5
Treatment of thyroid carcinoma: emphasis on high-dose 131I outpatient therapy.甲状腺癌的治疗:重点关注高剂量¹³¹I门诊治疗。
J Nucl Med Technol. 2002 Dec;30(4):165-71; quiz 172-3.
6
Leukemia after a small dose of radioiodine for metastatic thyroid cancer.
J Clin Endocrinol Metab. 1993 Nov;77(5):1423-6. doi: 10.1210/jcem.77.5.8077344.
7
Cumulative doses of adjunct 131I treatment depend on location of residual thyroid tissue after total thyroidectomy in differentiated thyroid cancer.分化型甲状腺癌全甲状腺切除术后辅助性¹³¹I治疗的累积剂量取决于残余甲状腺组织的位置。
J Pediatr Surg. 2007 May;42(5):853-6. doi: 10.1016/j.jpedsurg.2006.12.039.
8
Complications, sequela and dosimetry of iodine-131 therapy for thyroid carcinoma.甲状腺癌碘-131治疗的并发症、后遗症及剂量学
J Nucl Med. 1992 Dec;33(12):2214-21.
9
[Radioiodide therapy in pulmonary metastasis of differentiated thyroid cancer--factors affecting the success of I-131 therapy].
Nihon Igaku Hoshasen Gakkai Zasshi. 1987 Jul 25;47(7):962-70.
10
Subsequent malignancies in patients treated with 131-iodine for thyroid cancer.
Strahlenther Onkol. 1992 Jun;168(6):337-43.